Amended Statement of Changes in Beneficial Ownership (4/a)
May 05 2021 - 12:54PM
Edgar (US Regulatory)
FORM 4
[X]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
BESSER JAMES E |
2. Issuer Name and Ticker or Trading Symbol
Processa Pharmaceuticals, Inc.
[
PCSA
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner _____ Officer (give title below) __X__ Other (specify below) See Remarks |
(Last)
(First)
(Middle)
53 PALMERAS STREET, CARIBE PLAZA BUILDING, 6TH FLOOR |
3. Date of Earliest Transaction
(MM/DD/YYYY)
4/6/2021 |
(Street)
SAN JUAN, PR 00901
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
4/8/2021 |
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security (Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code (Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock, $0.01 par value | 4/6/2021 | | S | | 31771 | D | $10.91 | 1064300 | I | See footnotes (1)(2) |
Common Stock, $0.01 par value | 4/7/2021 | | S | | 16000 | D | $10.67 | 1048300 | I | See footnotes (1)(2) |
Common Stock, $0.01 par value | 4/8/2021 | | S | | 400000 | D | $10.76 | 648300 | I | See footnotes (1)(2) |
Common Stock, $0.01 par value | | | | | | | | 405000 | D | |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Explanation of Responses: |
(1) | These securities are directly owned by Manchester Explorer, L.P. and JEB Partners, L.P. These securities are indirectly beneficially owned by Manchester Management PR, LLC and Manchester Management Company, LLC as a result of having investment discretion over Manchester Explorer, L.P. and JEB Partners, L.P.; these securities may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC and Manchester Management Company, LLC. |
(2) | The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. |
Remarks: As of as of April 07, 2021, the Reporting Person is no longer subject to the reporting requirements of Section 16 of the Securities Exchange Act of 1934. The original Form 4, filed April 8, 2021, is being amended by this Form 4 amendment solely to correct an administrative error, which mistakenly inverted the ownership codes in Table I, Item 6, showing indirectly held shares as directly held and vice versa. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
BESSER JAMES E 53 PALMERAS STREET CARIBE PLAZA BUILDING, 6TH FLOOR SAN JUAN, PR 00901 |
|
|
| See Remarks |
Signatures
|
/s/ James E. Besser | | 5/5/2021 |
**Signature of Reporting Person | Date |
Processa Pharmaceuticals (NASDAQ:PCSA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Processa Pharmaceuticals (NASDAQ:PCSA)
Historical Stock Chart
From Apr 2023 to Apr 2024